Page: Contacts at the European Medicines Agency-2025/4/14

Document: CHMP-CAT - D80-210 Overview to final EPAR - Rev 04.25 (Revamp)-2025/4/14

Document: Guidance on the anonymisation of protected personal data and assessment of commercially confidential information during the preparation of RMPs (main body and annexes 4 and 6)-2025/4/11

Page: Template for the qualified person's (QP) declaration concerning good manufacturing practice compliance of active substance manufacture "The QP declaration template" - Scientific guideline-2025/4/11

Page: Medical devices-2025/4/11

Document: Questions & answers - Practical arrangements on the companion diagnostics consultation procedure to the European Medicines Agency by notified bodies-2025/4/11

Document: Questions & answers - Practical arrangements on the companion diagnostics consultation procedure to the European Medicines Agency by notified bodies - tracked changes-2025/4/11

Document: Overview of NCAs participating in the voluntary Simultaneous National Scientific Advice (SNSA) project-2025/4/11

Page: COVID-19 vaccines: key facts-2025/4/11

Page: Clinical investigation of medicinal products in the treatment of depression - Scientific guideline-2025/4/11